Article List

WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2016> 22> 2

Volume: 22 Issue: 2

1. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.	Page:199—211
2. Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma.	Page:199—211
3. Current status of laparoscopic liver resection for hepatocellular carcinoma.	Page:212—218
4. Current status of laparoscopic liver resection for hepatocellular carcinoma.	Page:212—218
5. Prevention of Hepatitis B reactivation in the setting of immunosuppression.	Page:219—237
6. Prevention of Hepatitis B reactivation in the setting of immunosuppression.	Page:219—237
7. Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?.	Page:238—240
8. Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?.	Page:238—240
9. The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy.	Page:241—249
10. The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy.	Page:241—249
11. Bone marrow metastasis presenting as bicytopenia originating from hepatocellular carcinoma.	Page:267—271
12. Drug-induced liver injury caused by iodine-131.	Page:272—275
13. A case of portal hypertension by presumed as plexiform neurofibroma at the hepatic hilum.	Page:276—280
14. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.	Page:281—285
15. Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases.	Page:286—291
16. Undifferentiated embryonal sarcoma of the liver in an adult patient.	Page:292—295
17. Liver imaging reporting and data system (LI-RADS) version 2014: understanding and application of the diagnostic algorithm.	Page:296—307
18. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.	Page:250—258
19. Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection.	Page:259—266